As a highly heterogenous cancer, CM harbours various genetic alteration including BRAF mutation, RAS mutation, NF1 mutations, etc., which plays an critical role in the biological behavior of CM and is closely related to the prognosis of CM patient [1]. This evidence concerns the gene BRAF and cutaneous mastocytosis.